LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_000314.8:c.1012_1016del
PTEN
· NP_000305.3:p.(Ser338LysfsTer3)
· NM_000314.8
GRCh37: chr10:89720860 TTCTCC>T
·
GRCh38: chr10:87961103 TTCTCC>T
Gene:
PTEN
Transcript:
NM_000314.8
Final call
Likely Pathogenic
PVS1 very strong
PM2 supporting
Variant details
Gene
PTEN
Transcript
NM_000314.8
Protein
NP_000305.3:p.(Ser338LysfsTer3)
gnomAD AF
ClinVar
OncoKB
Likely Oncogenic
Classification rationale
Interpretation summary
Generated evidence synthesis
1
Likely Pathogenic: PVS1 (very strong) reflects a truncating frameshift upstream of the PTEN VCEP NMD threshold.
2
Likely Pathogenic: PM2 (supporting) reflects absence from gnomAD v2.1 and v4.1.
Final determination:
Under Rule20 of the ClinGen PTEN Expert Panel Version 3.2 framework, one very strong pathogenic criterion plus two moderate criteria or one supporting criterion yields Likely Pathogenic; here PVS1 very strong plus PM2 supporting is the matched combination.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | Met | Met at very strong: the frameshift truncates PTEN at p.Ser338, before the VCEP p.D375 (c.1121) NMD threshold in transcript NM_000314.8. |
cspec
vcep_pvs1_decisiontree_pten
|
| PS1 | N/A | Not applicable: c.1012_1016del is a frameshift, p.(S338Kfs*3), rather than a missense amino-acid substitution required for this PS1 comparison. |
cspec
|
| PS2 | Not assessed | Not assessed: no proband diagnosis, parental testing, maternity/paternity confirmation, or family-history documentation is available for this variant. |
cspec
|
| PS3 | N/A | Not applicable: the PTEN VCEP functional rule covers high-confidence missense assay entries, whereas this variant is a frameshift absent under all three searched notations. |
cspec
vcep_mmc2
PMID:11237521
PMID:17218262
|
| PS4 | Not assessed | Not assessed: no variant-specific case-control enrichment or phenotype-specificity score is available for comparison with the PTEN PS4 thresholds. |
cspec
|
| PM1 | Not met | Not met: the variant begins at residue 338, outside the PTEN VCEP PM1 catalytic-motif intervals 90–94, 123–130, and 166–168. |
cspec
PMID:11237521
|
| PM2 | Met | Met, Supporting: the variant is absent from gnomAD v2.1 and v4.1, meeting the PTEN PM2 threshold below 0.00001 (0.001%). |
cspec
gnomad_v2
gnomad_v4
|
| PM3 | N/A | Not applicable: the PTEN VCEP specification explicitly designates PM3 as not applicable for this autosomal-dominant disorder. |
cspec
|
| PM4 | N/A | Not applicable: the variant is a frameshift with a premature stop, whereas PTEN PM4 covers in-frame length changes or stop-loss extensions. |
cspec
|
| PM5 | N/A | Not applicable: PM5 requires a missense change at a residue with a pathogenic or likely pathogenic alternate missense change, whereas this variant is a frameshift. |
cspec
|
| PM6 | Not assessed | Not assessed: no assumed de novo observation, parental results, proband diagnosis, family history, or independent occurrence count is documented. |
cspec
|
| PP1 | Not assessed | Not assessed: no affected relatives, segregation results, phase information, or meiosis count is documented for this variant. |
cspec
|
| PP2 | N/A | Not applicable: the PTEN VCEP PP2 rule is missense-specific, while this variant is the frameshift p.(S338Kfs*3). |
cspec
|
| PP3 | N/A | Not applicable: the variant is a frameshift, p.(S338Kfs*3), outside PP3's calibrated missense and splice-impact scope. |
cspec
|
| PP4 | N/A | Not applicable: the PTEN VCEP incorporates phenotype specificity into PS4 and marks PP4 as not applicable. |
cspec
|
| PP5 | N/A | Not applicable: the PTEN VCEP excludes PP5, and ClinVar has no exact-variant expert-panel Pathogenic or Likely pathogenic classification. |
cspec
clinvar
|
| BA1 | Not met | Not met: gnomAD v2.1 and v4.1 report the variant absent, not a filtering allele frequency greater than 0.00056 (0.056%). |
cspec
gnomad_v2
gnomad_v4
|
| BS1 | Not met | Not met: gnomAD v2.1 and v4.1 report absence, with no allele frequency in the PTEN BS1 range of 0.0000043 to 0.00056. |
cspec
gnomad_v2
gnomad_v4
|
| BS2 | Not met | Not met: the variant is absent from gnomAD v2.1 and v4.1, with no reported homozygous healthy individual. |
cspec
gnomad_v2
gnomad_v4
|
| BS3 | N/A | Not applicable: the PTEN VCEP benign functional rules require applicable missense or splicing assay evidence, but this frameshift has no exact entry under the searched variant notations. |
cspec
vcep_mmc2
PMID:11237521
PMID:17218262
|
| BS4 | Not assessed | Not assessed: no affected family members or variant-testing results demonstrate non-segregation in one or more families. |
cspec
|
| BP1 | N/A | Not applicable: the PTEN VCEP explicitly marks BP1 as not applicable, and this case variant is a truncating frameshift rather than a missense variant. |
cspec
|
| BP2 | Not assessed | Not assessed: no second pathogenic PTEN variant or cis/trans phase observation is available to meet the VCEP BP2 rule. |
cspec
|
| BP3 | N/A | Not applicable: the PTEN VCEP marks BP3 as not applicable, and this variant is a truncating frameshift rather than a repeat-region in-frame deletion. |
cspec
|
| BP4 | N/A | Not applicable: the variant is a frameshift, p.(S338Kfs*3), outside BP4's calibrated missense and splice-impact scope. |
cspec
|
| BP5 | Not assessed | Not assessed: no two qualifying cases with a highly penetrant alternate diagnosis and non-overlapping PTEN histories are documented. |
cspec
|
| BP6 | N/A | Not applicable: the PTEN VCEP excludes BP6, and ClinVar has no exact-variant expert-panel Benign or Likely benign classification. |
cspec
clinvar
|
| BP7 | N/A | Not applicable: the variant is a frameshift, p.(S338Kfs*3), not the synonymous variant required for BP7. |
cspec
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.